结论万古霉素耐药肠球菌肺感染发病率呈上升趋势，病死率高，需引起临床的高度重视。
Conclusion the morbidity of nosocomial pulmonary infections caused by VRE is rising and the mortality is very high, and this problem is worthy of particular mention.
从土壤中分离得到一株放线菌ar 1148，其代谢产物对万古霉素耐药肠球菌有较明显的抑菌活性。
An actinomycetes strain AR1148 was isolated from soil and its metabolites could inhibit the growth of VRE (vancomycin resistant Enterococcus).
目的探讨万古霉素耐药肠球菌(VRE)的同源性及主要耐药机制。
ObjectiveTo investigate the homology and resistant mechanism of vancomycin-resistant Enterococci (VRE) isolates.
耐万古霉素的肠球菌；耐药性；合理用药。
Vancomycin-resistant enterococci(VRE); Resistance; Rational drug use.
感染的肠球菌对万古霉素耐药的病人病死率最高，达92 % ，明显高于万古霉素敏感肠球菌肺感染的病死率（ 2 6% ） （P <0 0 5 ）。
The mortality of the patients infected by vancomycin-resistant enterococci was the highest (92%) and was higher than that of patients infected by vancomycin-sensitive enterococci (26%) ( P <0.05).
感染的肠球菌对万古霉素耐药的患者病死率最高。
Mortality case ofthe patients infected by vancomycin-resistant enterococci was the highest;
摘要：目的研究万古霉素耐药肠球菌(VRE)的耐药表型和基因特性。
Abstract: Objective To understand the susceptibility phenotype and genetic characteristics of vancomycin-resistant Enterococci (VRE).
摘要：目的研究万古霉素耐药肠球菌(VRE)的耐药表型和基因特性。
Abstract: Objective To understand the susceptibility phenotype and genetic characteristics of vancomycin-resistant Enterococci (VRE).
应用推荐